Sanofi-Aventis Zrt.
PolandAll drugs from this manufacturer
-
The vaccine is used to strengthen protection against diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio). It is used in children from 3 years of age, adolescents, and adults after a full course of primary vaccinations.
Dosage form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid Not less than 2 IU (2 Lf) tetanus toxoid Not less than 20 IU (5 Lf) pertussis toxoid 2.5 mcg fibrillar hemagglutinin 5 mcg pertactin 3 mcg fimbriae (type 2 and 3) 5 mcg inactivated poliovirus type 1 29 units of D3 antigen inactivated poliovirus type 2 7 units of D3 antigen inactivated poliovirus type 3 26 units of D3 antigen ATC: J07CA02